Mylan v. Research Corp. Techs. Mylan Pharms. Inc. v. Research Corp. Techs., Inc. (Fed. Cir. 2019) Patent claims non-obvious Read about it on Patently-O and PatentDocs… PatentDocs Post Patently-O Post Share: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Share on LinkedIn (Opens in new window) LinkedIn Print (Opens in new window) Print Gilead Wins Another Sofosbuvir Challenge: U. Minnesota v. GileadDateMarch 13, 2023In relation toCase LawAmerigen and Alembic petition to join Mylan’s IPR arguing that patent claims covering Toviaz® are obvious over Detrol®DateSeptember 7, 2016In relation toCase LawOnglyza® and Kombiglyze® XR (saxagliptin) Patent Survives Challenge from MylanDateSeptember 9, 2017In relation toCase Law